Two stocks in Healthcare
Danaher vs Regeneron Pharmaceuticals: profit, growth, debt and price compared
Regeneron Pharmaceuticals is stronger on 5 of 7 figures: profit margin, sales growth, debt, price for its expected profit and price trend. Danaher is stronger on 2: dividend and analysts' view.
Save both stocks to your watchlist and revisit their latest fundamentals.
| DanaherDHR | Regeneron PharmaceuticalsREGN | |
|---|---|---|
| Net margin | 16.9% | Stronger: 28.5% |
| Revenue growth, past year | +8.28% | Stronger: +36.27% |
| Debt to equity | 51.8% | Stronger: 8.1% |
| Forward P/E | 24.5× | Stronger: 13.3× |
| Dividend yield | Stronger: 0.71% | 0.39% |
| Analysts | Stronger: Strong buy · 21 | Buy · 27 |
| From its 200-day average | +9.3% | Stronger: +24.2% |
Share price over the past year
- Danaher+1.4%
- Regeneron Pharmaceuticals+30.4%
18 Nov 202518 Nov 2026
Danaher or Regeneron Pharmaceuticals: which is stronger?
- REGN
Which is more profitable?
Regeneron Pharmaceuticals keeps more of each sale as profit: 28.5% against 16.9%.
- REGN
Which is growing its sales faster?
Regeneron Pharmaceuticals is growing its sales faster: +36.27% over the past year, against +8.28%.
- REGN
Which has borrowed less?
Regeneron Pharmaceuticals has borrowed less: its debt is 8.1% of what its shareholders own, against 51.8% for Danaher.
- REGN
Which costs less for the profit it is expected to make?
Regeneron Pharmaceuticals costs less for the profit it is expected to make: 13.3× its forward earnings, against 24.5×.
- DHR
Which pays more in dividends?
Danaher pays more back in dividends for what a share costs: 0.71% a year, against 0.39%.
- DHR
Which do analysts rate higher?
Analysts are warmer on Danaher: Strong buy, against Buy for Regeneron Pharmaceuticals.
- REGN
Which is in the stronger price trend?
Regeneron Pharmaceuticals' price is in the stronger trend: 24.2% above its 200-day average, against 9.3% above.
What each company does
DHRDanaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Reports results on 27 January 2027
REGNRegeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
Reports results on 28 January 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.